Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly synthesizes potent, selective PPARdelta receptor agonists

Aug. 31, 2004

Potent, selective oxytocin receptor antagonist for preterm labor

Aug. 31, 2004

Biovitrum reports results from FABP4 inhibitor program

Aug. 31, 2004

MK-0431: a novel approach to type 2 diabetes

Aug. 30, 2004

Genistein reported to reduce hot flushes in postmenopausal women

Aug. 30, 2004

PPARpan agonist shows promise for type 2 diabetes and metabolic syndrome

Aug. 26, 2004

Metformin combined with DPP-IV inhibitor shows promise in treating type 2 diabetes

Aug. 26, 2004

Newly identified MCH receptor antagonists reported to reduce food intake and body weight gain

Aug. 25, 2004

BioMarin files IND for Phenoptin

Aug. 25, 2004

Financing at Agile Therapeutics to fund transdermal contraceptive

Aug. 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...